Financhill
Back

Legend Biotech Quote, Financials, Valuation and Earnings

Sell
44

LEGN
Legend Biotech

Last Price:
46.36
Seasonality Move:
19.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Legend Biotech Price Quote

$46.36
-0.01 (1.31%)
(Updated: May 17, 2024 at 4:49 AM ET)

Legend Biotech Key Stats

Sell
44
Legend Biotech (LEGN) is a Sell

Day range:
$45.20 - $46.43
52-week range:
$42.08 - $77.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
24.39
P/B ratio:
7.26%

Volume:
1M
Avg. volume:
1.1M
1-year change:
-36.26%
Market cap:
$8.5B
Revenue:
$285.1M
EPS:
$-2.58

How Much Does Legend Biotech Make?

Is Legend Biotech Growing As A Company?

  • What Is Legend Biotech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.59%
  • What Is Legend Biotech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Legend Biotech Stock Price Performance

  • Did Legend Biotech Stock Go Up Last Month?
    Legend Biotech share price went down by -7.48% last month
  • Did LEGN's Share Price Rise Over The Last Year?
    LEGN share price fell by -36.26% over the past 1 year

What Is Legend Biotech 52-Week High & Low?

Legend Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Legend Biotech?

  • How Much Debt Does Legend Biotech Have?
    Total long term debt quarterly is $286.4M
  • How Much Cash Does Legend Biotech Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Legend Biotech’s Book Value Per Share?
    Book value per share is 6.39

Is Legend Biotech Cash Flow Positive?

  • What Is LEGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$238.5M
  • What Is Legend Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $792.8M
  • What Is Legend Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$319.4M

Legend Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    LEGN return on invested capital is -32.38%
  • What Is Legend Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is -27.08%
  • What Is LEGN Return On Equity?
    ROE is a measure of profitability and is -40.06%

Legend Biotech Earnings Date & Stock Price

Legend Biotech Competitors

  • Who Are Legend Biotech's Competitors?
    Below is a list of companies who compete with Legend Biotech or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Bristol-Myers Squibb Co (BMY)
    • Exelixis Inc (EXEL)
    • Johnson & Johnson (JNJ)
    • 2seventy bio Inc (TSVT)

Legend Biotech Dividend Yield

Data Unavailable

Legend Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.06%
Revenue: 158.67% -33.51%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 85.37
Upside from Last Price: 84.1%

Major Shareholders

  • How many LEGN shares are owned by institutional investors?
    228.2M LEGN shares are owned by institutional investors
  • How many LEGN shares are owned by insiders?
    0 LEGN shares are owned by insiders